Lloyd’s Lab Central Fund invests in Axio and REOR20

Lloyd’s has confirmed that Axio and REOR20 will receive the first two investments from its Central Fund private markets allocation to support Lloyd’s Lab alumni.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com